Understanding these dependencies and defining at the molecular level if and how FAM46C is affecting sphingosine metabolism, could provide valuable insights into the broader applicability of targeting FAM46C-SphK1 interactions in cancer therapy. This evidence concerns the gene SPHK1 and cancer.